Showing results (241-250 of 275) with videos related to
Sort By:
Pageof 28
Nature|July 1, 2026
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancerNuria Vaquero-Siguero, Nikolaos Georgakopoulos, Maria C Puschhof, et al.Blood Advances|August 1, 2022
Disruption of stem cell niche-confined R-spondin 3 expression leads to impaired hematopoiesisAntonina V Kurtova, Melanie Heinlein, Simon Haas, et al.Nature Communications|January 28, 2021
Niche derived netrin-1 regulates hematopoietic stem cell dormancy via its receptor neogenin-1Simon Renders, Arthur Flohr Svendsen, Jasper Panten, et al.Nature Medicine|July 1, 2026
Clinical decision support in hematological malignancies using a case-grounded AI agentJulian Zoller, Michael Kalz, Xuewei Wu, et al.Nature Medicine|July 22, 2024
Proteomic signatures improve risk prediction for common and rare diseasesJulia Carrasco-Zanini, Maik Pietzner, Jonathan Davitte, et al.Blood|July 20, 2022
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1Maike Janssen, Christina Schmidt, Peter-Martin Bruch, et al.Cell Stem Cell|December 18, 2018
Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven ModulesAsaf Zviran, Nofar Mor, Yoach Rais, et al.EMBO Molecular Medicine|July 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastomaHamed Alborzinia, Zhiyi Chen, Umut Yildiz, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2025
Bispecific BAFF-R/BCMA CAR T cells control growth of heterogeneous plasma cells in multiple myelomaAgnese Fiori, Karin Zimmermann, Anna Li, et al.Nature Communications|March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasisAnna Lorentzen, Paul F Becker, Jan Kosla, et al.Pageof 28